2013 Fiscal Year Final Research Report
Functional analysis of osteoclastogenesis inhibitor
Project/Area Number |
24810025
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Chemical biology
|
Research Institution | Keio University |
Principal Investigator |
|
Project Period (FY) |
2012-08-31 – 2014-03-31
|
Keywords | ケミカルバイオロジー / 破骨細胞 / 骨粗鬆症 |
Research Abstract |
Bone homeostasis is maintained by both osteoclasts and osteoblasts. Osteoporosis is one of the bone diseases caused by collapse of bone homeostasis. Inhibitors of osteoclast differentiation are expected as new therapeutic agents for osteoporosis. We have found that TPh A inhibits osteoclast differentiation from bone marrow macrophages. We investigated the effects on RANKL-induced osteoclast differentiation of 50 TPh A derivatives in order to obtain a compound that inhibits osteoclastogenesis at a lower concentration than TPh A. We found that SUK-39 is the most potent osteoclastogenesis inhibitor. Moreover, RT-PCR analysis showed that SUK-39 suppressed RANKL-induced DC-STAMP and its transcription factor, c-fos mRNA level. These results indicated that SUK-39 inhibited osteoclast fusion by inhibiting expression of c-fos and subsequent DC-STAMP mRNA expression. SUK-39 would be a bioprobe for understanding the mechanisms of osteoclast fusion.
|
-
-
[Journal Article] Determination of topological structure of ARL6ip1 in cells : Identification of the essential binding region of ARL6ip1 for conophylline2013
Author(s)
Kuroda, M., Funasaki, S., Saitoh, T., Sasazawa, Y., Nishiyama, S., Umezawa, K. & Simizu, S.
-
Journal Title
FEBS Letters
Volume: 587
Pages: 3656–3660
Peer Reviewed
-
-
[Presentation] Antitumor activity of xanthohumol, an valosin-containing inhibitor of protein2013
Author(s)
○Shikata, Y., Kanagaki, S., Sasazawa, Y., Tashiro, E., Yoshimaru, T., Komatsu, M., Katagiri, T., Imoto, M.
Organizer
AACR-NCI-EORTC International conference MOLECULAR TARGETS AND CANCER THERAPEUTICS
Place of Presentation
Boston
Year and Date
20131000
-
-
-
-
-
-